Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Criteria of Chagas disease cure.

Literature DB >> 10677750

Criteria of Chagas disease cure.

J R Cançado¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1999 PMID： 10677750 DOI： 10.1590/s0074-02761999000700064

Source DB: PubMed Journal: Mem Inst Oswaldo Cruz ISSN： 0074-0276 Impact factor: 2.743

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Does Progressive Introduction of Benznidazole Reduce the Chance of Adverse Events in the Treatment of Chagas Disease?

Authors: Irene Losada Galván; Olaya Madrid Pascual; Juan María Herrero-Martínez; Ana Pérez-Ayala; Manuel Lizasoain Hernández
Journal: Am J Trop Med Hyg Date: 2019-06 Impact factor: 2.345

2. In silico approach for the identification of immunological properties of enolase from Trypanosoma cruzi and its possible usefulness as vaccine in Chagas disease.

Authors: Alejandro Carabarín-Lima; Olivia Rodríguez-Morales; María Cristina González-Vázquez; Lidia Baylón-Pacheco; Pedro A Reyes; Minerva Arce-Fonseca; José Luis Rosales-Encina
Journal: Parasitol Res Date: 2014-01-19 Impact factor: 2.289

3. Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.

Authors: L Murcia; B Carrilero; F Ferrer; M Roig; F Franco; M Segovia
Journal: Eur J Clin Microbiol Infect Dis Date: 2016-08-04 Impact factor: 3.267

4. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.

Authors: Ana Fernández-Villegas; Elena Pérez-Antón; Inmaculada Gómez; Adriana Egui; M Carmen Thomas; Bartolomé Carrilero; Ángel Del Pozo; Maialen Ceballos; Eduardo Andrés-León; Miguel Ángel López-Ruz; Eusebio Gainza; Enrique Oquiñena; Manuel Segovia; Manuel Carlos López
Journal: Antimicrob Agents Chemother Date: 2019-09-23 Impact factor: 5.191

5. Gene Expression Profiling and Functional Characterization of Macrophages in Response to Circulatory Microparticles Produced during Trypanosoma cruzi Infection and Chagas Disease.

Authors: Imran H Chowdhury; Sue-Jie Koo; Shivali Gupta; Lisa Yi Liang; Bojlul Bahar; Laura Silla; Julio Nuñez-Burgos; Natalia Barrientos; Maria Paola Zago; Nisha Jain Garg
Journal: J Innate Immun Date: 2016-12-01 Impact factor: 7.349

6. Use of the EIE-recombinant-Chagas-biomanguinhos kit to monitor cure of human Chagas' disease.

Authors: Edimilson D Silva; Valéria R A Pereira; Juliana A S Gomes; Virgínia Maria B Lorena; Joaquim R Cançado; Antonio G P Ferreira; Marco Aurélio Krieger; Samuel Goldenberg; Rodrigo Correa-Oliveira; Yara M Gomes
Journal: J Clin Lab Anal Date: 2002 Impact factor: 2.352

Criteria of Chagas disease cure.

1. Does Progressive Introduction of Benznidazole Reduce the Chance of Adverse Events in the Treatment of Chagas Disease?

2. In silico approach for the identification of immunological properties of enolase from Trypanosoma cruzi and its possible usefulness as vaccine in Chagas disease.

3. Success of benznidazole chemotherapy in chronic Trypanosoma cruzi-infected patients with a sustained negative PCR result.

4. A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.

5. Gene Expression Profiling and Functional Characterization of Macrophages in Response to Circulatory Microparticles Produced during Trypanosoma cruzi Infection and Chagas Disease.

6. Use of the EIE-recombinant-Chagas-biomanguinhos kit to monitor cure of human Chagas' disease.

7. Further insights into biological evaluation of new anti-Trypanosoma cruzi 5-nitroindazoles.

8. Serum-mediated activation of macrophages reflects TcVac2 vaccine efficacy against Chagas disease.

9. Serological evaluation of specific-antibody levels in patients treated for chronic Chagas' disease.

10. Impact of aetiological treatment on conventional and multiplex serology in chronic Chagas disease.